Effect of menaquinone supplementation in DMII

Phase 3

Recruiting

• Conditions: Type II Diabetes.; Diabetes mellitus due to underlying condition

• Registration Number: IRCT20100123003140N22
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

Men and non-postmenopausal women,
With type 2 diabetes (at least from 6 months prior to the study),
With desire to participate in the study,
Age of 20-55 years,
BMI 27-35 kg/m2,
Who use anti diabetic drugs.

Exclusion Criteria

Pregnancy, lactation, menopause, hormone therapy, use of vitamin K containing contraceptives, polycystic ovary syndrome;
Presence of diseases affecting vascular calcification or cardiac dysfunction;
History of bone, rheumatoid arthritis, thyroid, parathyroid, liver, kidney, intestine disease or malignancies;
Presence of infectious or inflammatory disease symptoms or recent surgery;
Use of insulin, corticosteroids and anticoagulant drugs such as warfarin and coumarin;
Adherence to a specific diet and consumption of any dietary supplements or weight reducing drugs for 3 month prior to the study;
Smoking.

Study & Design

• Study Type: interventional
• Study Design: Not specified